These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 105067

  • 1. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK, Kim Y, Schmeling D, Lindemann M, Verhoef J, Quie PG.
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [Abstract] [Full Text] [Related]

  • 2. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA, Van Dijk WC, Peters R, Van Der Tol ME, Peterson PK, Verhoef J.
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [Abstract] [Full Text] [Related]

  • 3. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J, Peterson P, Kim Y, Sabath LD, Quie PG.
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [Abstract] [Full Text] [Related]

  • 4. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA, Peterson PK, Nguyen BY, Sisson SP, Kim Y.
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [Abstract] [Full Text] [Related]

  • 5. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW, Peterson PK, Schmeling D, Bracke J, Kim Y, Quie PG.
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [Abstract] [Full Text] [Related]

  • 6. The role of complement in the opsonization of mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Baltimore RS, Shedd DG.
    Pediatr Res; 1983 Dec; 17(12):952-8. PubMed ID: 6419197
    [Abstract] [Full Text] [Related]

  • 7. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM, Bortolussi R, Issekutz AC, Gillespie T.
    Clin Invest Med; 1982 Dec; 5(2-3):125-8. PubMed ID: 6811181
    [Abstract] [Full Text] [Related]

  • 8. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L, Hällgren R, Venge P.
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [Abstract] [Full Text] [Related]

  • 9. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T, Frisk A, Purvèn M, Nilsson LA.
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [Abstract] [Full Text] [Related]

  • 10. The key role of peptidoglycan in the opsonization of Staphylococcus aureus.
    Peterson PK, Wilkinson BJ, Kim Y, Schmeling D, Douglas SD, Quie PG, Verhoef J.
    J Clin Invest; 1978 Mar; 61(3):597-609. PubMed ID: 641141
    [Abstract] [Full Text] [Related]

  • 11. Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.
    Reed WP.
    Immunology; 1975 Jun; 28(6):1051-9. PubMed ID: 1132888
    [Abstract] [Full Text] [Related]

  • 12. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae.
    Edwards KM, Gewurz H, Lint TF, Mold C.
    J Immunol; 1982 Jun; 128(6):2493-6. PubMed ID: 7077077
    [Abstract] [Full Text] [Related]

  • 13. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS, Grebner JV, Kim Y, Quie PG.
    Yale J Biol Med; 1978 Jun; 51(5):527-38. PubMed ID: 34937
    [Abstract] [Full Text] [Related]

  • 14. Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
    Meshulam T, Verbrugh HA, Verhoef J.
    Eur J Clin Microbiol; 1982 Apr; 1(2):112-7. PubMed ID: 6816585
    [Abstract] [Full Text] [Related]

  • 15. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.
    Verbrugh HA, Lee DA, Elliott GR, Keane WF, Hoidal JR, Peterson PK.
    Immunology; 1985 Apr; 54(4):643-53. PubMed ID: 3980045
    [Abstract] [Full Text] [Related]

  • 16. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
    Kerr MA, Falconer JS, Bashey A, Beck JS.
    Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
    [Abstract] [Full Text] [Related]

  • 17. The septic burned patient: a model for studying the role of complement and immunoglobulins in opsonization of opportunist micro-organisms.
    Bjornson AB, Altemeier WA, Bjornson HS.
    Ann Surg; 1979 Apr; 189(4):515-27. PubMed ID: 109057
    [Abstract] [Full Text] [Related]

  • 18. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.
    Yamamura M, Valdimarsson H.
    Immunology; 1978 Apr; 34(4):689-94. PubMed ID: 363601
    [Abstract] [Full Text] [Related]

  • 19. Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
    Williams AJ, Hastings MJ, Easmon CS, Cole PJ.
    Immunology; 1980 Dec; 41(4):903-11. PubMed ID: 7007217
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime.
    van Bronswijk H, Verbrugh HA, Heezius HC, Renders NH, Fleer A, van der Meulen J, Oe PL, Verhoef J.
    Immunology; 1989 May; 67(1):81-6. PubMed ID: 2737697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.